title: Identification of growth inhibiting compounds in a Giardia lamblia high-throughput screen.
abstract: Giardia lamblia is one of the most common eukaryotic pathogens and is classified by the CDC as a category B agent of bioterrorism. In a departure from more traditional research focused on specific pathways or molecules, we have developed a high-throughput assay for screening libraries of small compounds for inhibitors and enhancers of trophozoite multiplication. Following a 24-h period of culture in 384-well plates in the presence of compounds, trophozoites were fixed, stained and enumerated. Quadruplicate screening of 1520 compounds from two libraries of known bioactives detected numerous inhibitory compounds. Based on a stringent cut-off of 5 standard deviations from the plate mean, 50 compounds (3.3%) were inhibitory. The activity of 3 compounds was confirmed in conventional culture. Although not meeting the threshold, one compound (indirubin) was identified as an agonist of trophozoite proliferation. Demonstrating the potential of high-throughput screening for rapidly finding new compounds which perturb G. lamblia multiplication, most of the hits identified by high-throughput screening do not appear to have been tested previously for their ability to affect G. lamblia trophozoites. High-throughput screening of bioactive compounds will open new avenues to a system-wide analysis of pathways affecting G. lamblia proliferation, and eventually to other phases of the life cycle.
authors.affiliation: Tufts Cummings School of Veterinary Medicine, 200 Westboro Road, North Grafton, MA 01536, USA.
authors.forename: Rubén
authors.initials: R
authors.lastname: Bonilla-Santiago
authors.forename: Zhijin
authors.initials: Z
authors.lastname: Wu
authors.forename: Linghui
authors.initials: L
authors.lastname: Zhang
authors.forename: Giovanni
authors.initials: G
authors.lastname: Widmer
mesh_terms: D000818:Animals; D001681:Biological Assay / Q000379:methods; D016829:Giardia lamblia / Q000187:drug effects / Q000254:growth & development*; D006131:Growth Inhibitors / Q000737:chemistry*; D006403:Hematologic Tests; D053058:Trophozoites / Q000187:drug effects
chemical_list: D006131:Growth Inhibitors
references.citation: Cell Microbiol. 2001 Jan;3(1):55-62
references.pmid: 11207620
references.citation: Eukaryot Cell. 2007 Dec;6(12):2354-64
references.pmid: 17766466
references.citation: Clin Microbiol Rev. 2001 Jul;14(3):447-75
references.pmid: 11432808
references.citation: FASEB J. 1991 Jan;5(1):98-103
references.pmid: 1703974
references.citation: J Biomol Screen. 2008 Feb;13(2):159-67
references.pmid: 18216390
references.citation: J Eukaryot Microbiol. 2006;53 Suppl 1:S182-3
references.pmid: 17169054
references.citation: Int J Parasitol. 2008 Mar;38(3-4):353-69
references.pmid: 17964578
references.citation: Exp Parasitol. 2005 May;110(1):62-72
references.pmid: 15804380
references.citation: J Struct Biol. 2004 Aug;147(2):102-15
references.pmid: 15193639
references.citation: Int J Parasitol. 2008 Jul;38(8-9):935-44
references.pmid: 18289546
references.citation: J Biomol Screen. 2003 Dec;8(6):634-47
references.pmid: 14711389
references.citation: J Parasitol. 1980 Apr;66(2):347-50
references.pmid: 6248623
references.citation: Trans R Soc Trop Med Hyg. 1983;77(4):487-8
references.pmid: 6636276
references.citation: Eukaryot Cell. 2008 Apr;7(4):569-74
references.pmid: 18296622
references.citation: Gastroenterology. 1982 Oct;83(4):797-803
references.pmid: 7106510
references.citation: Mol Microbiol. 2006 Jan;59(1):202-11
references.pmid: 16359329
references.citation: Eukaryot Cell. 2006 Apr;5(4):753-61
references.pmid: 16607022
references.citation: Infect Immun. 2001 Dec;69(12):7866-72
references.pmid: 11705969
references.citation: Int J Parasitol. 2003 Jan;33(1):3-28
references.pmid: 12547343
references.citation: Genome Biol. 2006;7(10):R100
references.pmid: 17076895
references.citation: Eukaryot Cell. 2006 Apr;5(4):781-3
references.pmid: 16607025